Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Peabody
University of New Mexico Health Scis Ctr, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Agilvax
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Peabody has equity interest in Agilvax. Some of the vaccine selection technology used in this study is the same technology that UNM has licensed to Agilvax. His duties in this study at UNM and his equity interests in Agilvax created the potential for a financial conflict.
Vaccine-mediated control of bacterial virulence regulation and infection
PROJECT NARRATIVE: Staphylococcus aureus (SA) is the most common cause of skin and soft tissue infection (SSTI). SA causes recurrent infections, particularly in highly susceptible patient populations with reduced immune function. We have developed a vaccine to control SA production of secreted factors that drive pathogenesis during infection. We aim to test the efficacy of this vaccine in models of reduced immune function. This vaccine could significantly improve the health of patients who regularly suffer from SA skin infections.
Filed on February 27, 2019.
Tell us what you know about David Peabody's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “David Peabody”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Peabody | University of New Mexico Health Scis Ctr | Conflict of Interest | University of New Mexico Health Sciences Center | Value cannot be readily determined |
| David Peabody | Massachusetts General Hospital | Conflict of Interest | Agilvax Technology | Value cannot be readily determined |
| David Peabody | University of New Mexico Health Scis Ctr | Conflict of Interest | UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER | Value cannot be readily determined |
| David Peabody | University of New Mexico Health Scis Ctr | Conflict of Interest | Agilvax, Inc | Value cannot be readily determined |
| David Peabody | University of New Mexico Health Scis Ctr | Conflict of Interest | Agilvax, Inc | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.